A detailed history of Clearview Wealth Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clearview Wealth Advisors LLC holds 7,337 shares of PFE stock, worth $203,234. This represents 0.21% of its overall portfolio holdings.

Number of Shares
7,337
Previous 7,747 5.29%
Holding current value
$203,234
Previous $223,000 8.97%
% of portfolio
0.21%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$25.89 - $29.73 $10,614 - $12,189
-410 Reduced 5.29%
7,337 $203,000
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $156 - $203
-6 Reduced 0.08%
7,747 $223,000
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $20,954 - $24,494
-653 Reduced 7.77%
7,753 $257,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $25,175 - $29,127
-697 Reduced 7.66%
8,406 $308,000
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $143,773 - $187,172
-3,650 Reduced 28.62%
9,103 $371,000
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $1,503 - $1,962
-36 Reduced 0.28%
12,753 $653,000
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $15,140 - $18,483
346 Added 2.78%
12,789 $560,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $12,376 - $14,675
266 Added 2.18%
12,443 $652,000
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $10,659 - $13,208
-233 Reduced 1.88%
12,177 $630,000
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $61,525 - $91,201
-1,489 Reduced 10.71%
12,410 $733,000
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $63,035 - $80,974
1,606 Added 13.06%
13,899 $598,000
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $27,758 - $31,445
773 Added 6.71%
12,293 $481,000
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $2,109 - $2,379
-63 Reduced 0.54%
11,520 $417,000
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $387,683 - $492,972
11,583 New
11,583 $426,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clearview Wealth Advisors LLC Portfolio

Follow Clearview Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearview Wealth Advisors LLC with notifications on news.